High-grade astrocytoma treated concomitantly with estramustine and radiotherapy

Journal of Neuro-Oncology

Volumn 78, Issue 3, 2006, Pages 321-326

  Henriksson, Roger ^a   Malmström, Annika ^b   Bergström, Per ^a   Bergh, Gertrud ^g   Trojanowski, Thomas ^f   Andreasson, Lars ^c   Blomquist, Erik ^d   Jonsborg, Sonny ^e   Edekling, Tomas ^a   Salander, Pär ^a   Brännström, Thomas ^a   Bergenheim, A Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e BORÅS HOSPITAL   (Sweden)

^f MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^g NONE

Author keywords

Astrocytoma; Chemotherapy; Estramustine; Glioma; Radiotherapy

Indexed keywords

CORTICOSTEROID; ESTRAMUSTINE PHOSPHATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GYNECOMASTIA; HUMAN; HYPERTHYROIDISM; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; NAUSEA; OPEN STUDY; PNEUMONIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STATISTICAL SIGNIFICANCE; THROMBOPHLEBITIS; URINARY TRACT INFECTION; VAGINA BLEEDING; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; ESTRAMUSTINE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745776473     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9106-9     Document Type: Article

References (27)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352: 987-996, 2005
2. Bergenheim AT, Bjork P, Bergh J, von Schoultz E, Svedberg H, Henriksson R Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma Cancer Res 54: 4974-4979, 1994
3. von Schoultz E, Gunnarsson PO, Henriksson R Uptake, metabolism and antiproliferative effect of estramustine phosphate in human glioma cell lines Anticancer Res 9: 1713-1716, 1989
4. von Schoultz E, Lundblad D, Bergh J, Grankvist K, Henriksson R Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines Br J Cancer 58: 326-329, 1988
5. Yoshida D, Piepmeier JM, Teramoto A In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate Neurosurgery 39: 360-366, 1996
6. Bergenheim AT, Gunnarsson PO, Edman K, von Schoultz E, Hariz MI, Henriksson R Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans Br J Cancer 67: 358-361, 1993
7. Vallbo C, Bergenheim T, Bergh A, Grankvist K, Henriksson R DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain - suggesting an apoptotic cell death Br J Cancer 71: 717-720, 1995
8. Vallbo C, Bergenheim AT, Bergstrom P, Gunnarsson PO, Henriksson R Apoptotic tumor cell death induced by estramustine in patients with malignant glioma Clin Cancer Res 4: 87-91, 1998
9. von Schoultz E, Lundgren E Henriksson R Effects of estramustine and its constituents on human malignant glioma cells Anticancer Res 10: 693-696, 1990
10. Bergenheim AT, Henriksson R Pharmacokinetics and pharmacodynamics of estramustine phosphate Clin Pharmacokinet 34:163-172, 1998 Review
11. Bergenheim AT, Zackrisson B, Elfverson J, Roos G, Henriksson R Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo J Neurooncol 23: 191-200, 1995
12. Johansson M, Bergenheim AT, Widmark A, Henriksson R: Effects of radiotherapy and estramustine on the microvasculature in malignant glioma Br J Cancer 80: 142-148, 1999
13. Kim JH, Khil MS, Kim SH, Ryu S, Gabel M Clinical and biological studies of estramustine phosphate as a novel radiation sensitizer Int J Radiat Oncol Biol Phys 15: 555-557, 1994
14. Yoshida D, Piepmeier J, Weinstein M Estramustine sensitizes human glioblastoma cells to irradiation Cancer Res 54:1415-1417,1994
15. Landy H, Markoe A, Potter P, Lasalle G, Marini A, Savaraj N, Reis I, Heros D, Wangpaichitr M, Feun L Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma J Neuro-Oncol 67: 215-220, 2004
16. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85: 365-376, 1993
17. Fisher BJ, Scott C, Macdonald DR, Coughlin C, Curran WJ Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507 J Clin Oncol 19(4): 1111-1117, 2001
18. Del Rowe J, Scott C, Werner-Wasik M, Bahary JP, Curran WJ, Urtasun RC, Fisher B Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme J Clin Oncol18: 1254-1259, 2000
19. Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytomaInt J Radiat Oncol Biol Phys 44: 535-543, 1999
20. Piepmeier JM, Keefe DL, Weinstein MA, Yoshida D, Zielinski J, Lin TT, Chen Z, Naftolin F Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells Neurosurgery 32: 422-430;1993 discussion 430-431
21. Kallio M, Sankila R, Jaaskelainen J, Karjalainen S, Hakulinen T A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984 Cancer 68: 1394-1400, 1991
22. Kayser-Gatchalian MC, Kayser K Thrombosis and intracranial tumorsJ Neurol 209: 217-224, 1975
23. Hamilton MG, Hull RD, Pineo GF Prophylaxis of venous thromboembolism in brain tumor patients J Neurooncol 22: 111-126, 1994
24. Marras LC, Geerts WH, Perry JR The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review Cancer 89: 640-646, 2000
25. von Schoultz E, Bergenheim T, Grankvist K, Henriksson R Estramustine binding protein in human brain-tumor tissue J Neurosurg 74: 962-964, 1991
26. Fluchter SH, Nelde HJ, Bjork P, Muntzing J, Bichler KH Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: An immunohistochemical study Prostate 14: 27-43, 1989
27. Walz PH, Bjork P, Gunnarsson PO, Edman K, Hartley-Asp B Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue Clin Cancer Res 4: 2079-2084, 1989